LUCILLE DIPAOLA: Open Payments
NPI 1801679956 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $34 |
| ABIOMED | 1 | $30 |
| Edwards Lifesciences Corporation | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $28 |
| Boston Scientific Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Ozempic, SAPIEN 3 Ultra RESILIA, INGREZZA, Veozah, General - Pain Management, Kerendia.
Industry payments across CO — which companies pay providers there.
